Abstract
Inborn errors of metabolism (IEMs) that present with abnormal imaging findings in the second half of pregnancy are mainly lysosomal storage disorders (LSDs), cholesterol synthesis disorders (CSDs), glycogen storage disorder type IV (GSD IV), peroxisomal disorders, mitochondrial fatty acid oxidation defects (FAODs), organic acidurias, aminoacidopathies, congenital disorders of glycosylation (CDGs), and transaldolase deficiency. Their biological investigation requires fetal material. The supernatant of amniotic fluid (AF) is useful for the analysis of mucopolysaccharides, oligosaccharides, sialic acid, lysosphingolipids and some enzyme activities for LSDs, 7- and 8-dehydrocholesterol, desmosterol and lathosterol for CSDs, acylcarnitines for FAODs, organic acids for organic acidurias, and polyols for transaldolase deficiency. Cultured AF or fetal cells allow the measurement of enzyme activities for most IEMs, whole-cell assays, or metabolite measurements. The cultured cells or tissue samples taken after fetal death can be used for metabolic profiling, enzyme activities, and DNA extraction. Fetal blood can also be helpful. The identification of vacuolated cells orients toward an LSD, and plasma is useful for diagnosing peroxisomal disorders, FAODs, CSDs, some LSDs, and possibly CDGs and aminoacidopathies. We investigated AF of 1700 pregnancies after exclusion of frequent etiologies of nonimmune hydrops fetalis and identified 108 fetuses affected with LSDs (6.3 %), 29 of them with mucopolysaccharidosis type VII (MPS VII), and six with GSD IV (0.3 %). In the AF of 873 pregnancies, investigated because of intrauterine growth restriction and/or abnormal genitalia, we diagnosed 32 fetuses affected with Smith-Lemli-Opitz syndrome (3.7 %).
Similar content being viewed by others
References
Al Kaissi A, Kurz H, Bock W, Pärtan G et al (2014) Agenesis of the corpus callosum and skeletal deformities in two unrelated patients: Analysis via MRI and Radiography. Case Rep Orthop 2014:186973
Alfadhel M, Alrifai MT, Trujillano D et al (2015) Asparagine synthetase deficiency: new inborn errors of metabolism. JIMD Rep 22:11–16
Anderson G, Smith VV, Malone M, Sebire NJ (2005) Blood film examination for vacuolated lymphocytes in the diagnosis of metabolic disorders; retrospective experience of more than 2,500 cases from a single centre. J Clin Pathol 58:1305–1310
Andersson HC, Kratz L, Kelley R (2002) Desmosterolosis presenting with multiple congenital anomalies and profound developmental delay. Am J Med Genet 113(4):315–319
Bandaralage SP, Farnaghi S, Dulhunty JM, Kothari A (2016) Antenatal and postnatal radiologic diagnosis of holocarboxylase synthetase deficiency: a systematic review. Pediatr Radiol 46:357–364
Baroy T, Koster J, Stromme P et al (2015) A novel type of rhizomelic chondrodysplasia punctata, RCDP5, is caused by loss of the PEX5 long isoform. Hum Mol Genet 24:5845–5854
Bellini C, Donarini G, Paladini D et al (2015) Etiology of non-immune hydrops fetalis: An update. Am J Med Genet A 167A:1082–1088
Benoist JF, Imbard A, Dreux S et al (2007) Antenatal biochemical expression of cystinuria and relation to fetal hyperechogenic colon. Clin Chem 53:149–150
Boemer F, Deberg M, Schoos R et al (2016) Diagnostic pitfall in antenatal manifestations of CPT II deficiency. Clin Genet 89:193–197
Brasseur-Daudruy M, Garel C, Brossard V et al (2006) Hyper-echogenic colon: a prenatal sign of cystinuria? Prenat Diagn 26:1254–1255
Brunetti-Pierri N, Corso G, Rossi M et al (2002) Lathosterolosis, a novel multiple-malformation / mental retardation syndrome due to deficiency of 3-beta-hydroxysteroid-delta-5-desaturase. Am J Hum Genet 71:952–958
Buchert R, Tawamie H, Smith C et al (2014) A peroxisomal disorder of severe intellectual disability, epilepsy, and cataracts due to fatty acyl-CoA reductase 1 deficiency. Am J Hum Genet 95:602–610
Burin MG, Scholz AP, Gus R et al (2004) Investigation of lysosomal storage diseases in nonimmune hydrops fetalis. Prenat Diagn 24:653–657
Cañueto J, Girós M, Ciria S et al (2012) Clinical, molecular and biochemical characterization of nine Spanish families with Conradi-Hünermann-Happle syndrome: new insights into CDPX2 with a comprehensive review of literature. Br J Dermatol 166:830–838
Carmi-Nawi N, Malinger G, Mandel H et al (2011) Prenatal brain disruption in molybdenum cofactor deficiency. J Child Neurol 26:460–464
Chuang WL, Pacheco J, Cooper S et al (2014) Lyso-sphingomyelin is elevated in dried blood spots of Niemann-Pick B patients. Mol Genet Metab 111:209–211
Clayton P, Winchester B, Di Tomaso E et al (1993) Carbohydrate-deficient glycoprotein syndrome: normal glycosylation in the fetus. Lancet 341:956
Dacremont G, Vincent G (1995) Assay of plasmalogens and polyunsaturated fatty acids (PUFA) in erythrocytes and fibroblasts. J Inherit Metab Dis 18(Suppl 1):84–89
de Koning TJ (2013) Amino acid synthesis deficiencies. Handb Clin Neurol 113:1775–1783
de Koning TJ, Duran M, Van Maldergem L et al (2002) Congenital microcephaly and seizures due to 3-phosphoglycerate dehydrogenase deficiency: outcome of treatment with amino acids. J Inherit Metab Dis 25:119–125
de Vet EC, IJlst L, Oostheim W et al (1999) Ether lipid biosynthesis. Alkyl-dihydroxyacetonephosphate synthase protein deficiency leads to reduced dihydroxyacetonephosphate acyltransferase activities. J Lipid Res 40:1998–2003
Dimauro S, Garone C (2011) Metabolic disorders of fetal life: glycogenoses and mitochondrial defects of the mitochondrial respiratory chain. Semin Fetal Neonatal Med 16:181–189
Dreux S, Salomon LJ, Rosenblatt J et al (2015) Biochemical analysis of ascites fluid as an aid to etiological diagnosis: a series of 100 cases of nonimmune fetal ascites. Prenat Diagn 35:214–220
Dugan RB, Pletneva MA, Salari K et al (2014) Nonimmune fetal hydrops and lysosomal storage disease: the finding of vacuolated lymphocytes in ascitic fluid in two cases. Prenat Diagn 34(2):199–201
Edwards M, McKenzie F, O’callaghan S et al (2006) Prenatal diagnosis of congenital disorder of glycosylation type Ia (CDG-Ia) by cordocentesis and transferrin isoelectric focussing of serum of a 27-week fetus with non-immune hydrops. Prenat Diagn 26:985–988
Froissart R, Cheillan D, Bouvier R et al (2005) Clinical, morphological, and molecular aspects of sialic acid storage disease manifesting in utero. J Med Genet 42:829–836
Giese AK, Mascher H, Grittner U et al (2015) A novel, highly sensitive and specific biomarker for Niemann-Pick type C1 disease. Orphanet J Rare Dis 10:78
Gimovsky AC, Luzi P, Berghella V (2015) Lysosomal storage disease as an etiology of nonimmune hydrops. Am J Obstet Gynecol 212:281–290
Goldenberg A, Wolf C, Chevy F et al (2004) Antenatal manifestations of Smith-Lemli-Opitz (RSH) syndrome: a retrospective survey of 30 cases. Am J Med Genet A 124A:423–436
Häberle J, Görg B, Rutsch F et al (2005) Congenital glutamine deficiency with glutamine synthetase mutations. N Engl J Med 353:1926–1933
Ho AC, Fung CW, Siu TS et al (2014) Lathosterolosis: a disorder of cholesterol biosynthesis resembling Smith-Lemli-Opitz syndrome. JIMD Rep 12:129–134
Jakobs C (1989) Prenatal diagnosis of inherited metabolic disorders by stable isotope dilution GC-MS analysis of metabolites in amniotic fluid: review of four years experience. J Inherit Metab Dis 12(suppl2):267–270
Jiang X, Sidhu R, Porter FD et al (2011) A sensitive and specific LC-MS/MS method for rapid diagnosis of Niemann-Pick C1 disease from human plasma. J Lipid Res 52:1435–1445
Kattner E, Schafer A, Harzer K (1997) Hydrops fetalis: manifestation in lysosomal storage diseases including Farber disease. Eur J Pediatr 156:292–295
Konstantinidou A, Karadimas C, Waterham HR et al (2008) Pathologic, radiographic and molecular findings in three fetuses diagnosed with HEM/Greenberg skeletal dysplasia. Prenat Diagn 28:309–312
Lacalm A, Nadaud B, Massoud M et al (2016) Prenatal diagnosis of cobblestone lissencephaly associated with Walker-Warburg syndrome based on a specific sonographic pattern. Ultrasound Obstet Gynecol 47:117–122
Lefebvre M, Dufernez F, Bruel AL et al (2015) Severe X-linked chondrodysplasia punctata in nine new female fetuses. Prenat Diagn 35:675–684
Lepais L, Cheillan D, Collardeau-Frachon S et al (2015) ALG3-CDG: Report of two siblings with antenatal features carrying homozygous p.Gly96Arg mutation. Am J Med Genet A 167:2748–2754
Léticée N, Bessières-Grattagliano, Dupré T et al (2010) Should PMM2-deficiency (CDG Ia) be searched in every case of unexplained hydrops fetalis? Mol Genet Metab 101:253–277
L’herminé-Coulomb A, Beuzen F, Bouvier R et al (2005) Fetal type IV glycogen storage disease: clinical, enzymatic, and genetic data of a pure muscular form with variable and early antenatal manifestations in the same family. Am J Med Genet A 139A:118–222
Machin GA (1989) Hydrops revisited: literature review of 1,414 cases published in the 1980. Am J Med Genet 34:366–390
Matthijs G, Schollen E, Cassiman JJ et al (1998) Prenatal diagnosis in CDG1 families: beware of heterogeneity. Eur J Hum Genet 6:99–104
Mellerio C, Marignier S, Roth P et al (2008) Prenatal cerebral ultrasound and MRI findings in glutaric aciduria Type 1: a de novo case. Ultrasound Obstet Gynecol 31:712–714
Nada MA, Vianey-Saban C, Roe CR et al (1996) Prenatal diagnosis of mitochondrial fatty acid oxidation defects. Prenat Diagn 16:117–124
Ottolenghi C, Hubert L, Allanore Y et al (2011) Clinical and biochemical heterogeneity associated with fumarase deficiency. Hum Mutat 32:1046–1052
Pagan C, Latour P, Ruet S et al (2015) Contribution of plasmatic biomarkers to the diagnosis of Niemann-Pick type C. J Inherit Metab Dis 38(Suppl1):S57
Patel KP, O’Brien TW, Subramony SH et al (2012) The spectrum of pyruvate dehydrogenase complex deficiency: clinical, biochemical and genetic features in 371 patients. Mol Genet Metab 105:34–43
Paupe A, Bidat L, Sonigo P et al (2002) Prenatal diagnosis of hypoplasia of the corpus callosum in association with non-ketotic hyperglycinemia. Ultrasound Obstet Gynecol 20:616–619
Pettazzoni M, Piraud M, Froissart R et al (2015a) LS-MS/MS lysosphingolipids measurement in plasma for the screening and follow-up of lysosomal storage diseases. J Inherit Metab Dis 38(Suppl 1):S56
Pettazzoni M, Streichenberger N, Mezin P et al (2015b) Congenital and perinatal glycogen storage disease type IV: clinical, pathological and biological data in 5 cases. J Inherit Metab Dis 38(Suppl 1):S182
Piraud M, Froissart R, Mandon G, Bernard A, Maire I (1996) Amniotic fluid for screening of lysosomal storage diseases presenting in utero (mainly as non-immune hydrops fetalis). Clin Chim Acta 248:143–155
Pitt JJ, Eggington M, Kahler SG (2002) Comprehensive screening of urine samples for inborn errors of metabolism by electrospray tandem mass spectrometry. Clin Chem 48:1970–1980
Prick BW, Hop WC, Duvekot JJ (2012) Maternal phenylketonuria and hyperphenylalaninemia in pregnancy: pregnancy complications and neonatal sequelae in untreated and treated pregnancies. Am J Clin Nutr 95:374–382
Rigaud C, Lebre AS, Touraine R et al (2013) Natural history of Barth syndrome: a national cohort study of 22 patients. Orphanet J Rare Dis 8:70–82
Rolfs A, Giese AK, Grittner U et al (2013) Glucosylsphingosine is a highly sensitive and specific biomarker for primary diagnostic and follow-up monitoring in Gaucher disease in a non-Jewish, Caucasian cohort of Gaucher disease patients. PLoS One 8:e79732
Rolland MO, Cuisset L, Le Bozec J et al (2005) First-trimester enzymatic and molecular prenatal diagnosis of mevalonic aciduria. J Inker Metab Dis 28:1141–1142
Rossi M, d’Armento M, Parisi I et al (2007) Clinical phenotype of lathosterolosis. Am J Med Genet A 143:2371–2381
Rossi M, Hall CM, Bouvier R et al (2015) Radiographic features of the skeleton in disorders of post-squalene cholesterol biosynthesis. Pediatr Radiol 45:965–976
Schaefer AM, Taylor RW, Turnbull DM, Chinnery PF (2004) The epidemiology of mitochondrial disorders–past, present and future. Biochim Biophys Acta 1659:115–120
Schmidt MR, Birkebaek N, Gonzalez I, Sunde L (2004) Barth syndrome without 3-methylglutaconic aciduria. Acta Paediatr 93:419–421
Schollen E, Kjaergaard S, Legius E et al (2000) Lack of Hardy-Weinberg equilibrium for the most prevalent PMM2 mutation in CDG-Ia (congenital disorders of glycosylation type Ia). Eur J Hum Genet 8:367–371
Schwarzer V, Haas D, Hoffmann GF et al (2008) Abnormal prenatal ultrasound findings in mevalonic aciduria. Prenat Diagn 28:257–258
Shigematsu Y, Hata I, Nakai A et al (1996) Prenatal diagnosis of organic acidemias based on amniotic fluid levels of acylcarnitines. Pediatr Res 39:680–684
Spiegel R, Raas-Rothschild A, Reish O et al (2009) The clinical spectrum of fetal Niemann-Pick type C. Am J Med Genet 149A:446–450
Steinberg S, Chen L, Wei L et al (2004) The PEX Gene Screen: molecular diagnosis of peroxisome biogenesis disorders in the Zellweger syndrome spectrum. Mol Genet Metab 83:252–263
Steward CG, Newbury-Ecob RA, Hastings R et al (2010) Barth syndrome: an X-linked cause of fetal cardiomyopathy and stillbirth. Prenat Diagn 30:970–976
Suormala T, Fowler B, Jakobs C et al (1998) Late-onset holocarboxylase synthetase-deficiency: pre- and post-natal diagnosis and evaluation of effectiveness of antenatal biotin therapy. Eur J Pediatr 157:570–575
Taroni F, Gellera C, Cavadini P et al (1994) Lethal carnitine palmitoyltransferase (CPT) II deficiency in newborns: a molecular-genetic study. Am J Hum Genet 55:A265
Tavares MV, Santos MJ, Domingues AP et al (2013) Antenatal manifestations of mitochondrial disorders. J Inherit Metab Dis 36:805–811
Thuy LP, Belmont J, Nyhan WL (1999) Prenatal diagnosis and treatment of holocarboxylase synthetase deficiency. Prenat Diagn 19:108–112
Valayannopoulos V, Verhoeven NM, Mention K et al (2006) Transaldolase deficiency: a new cause of hydrops fetalis and neonatal multi-organ disease. J Pediatr 149:713–717
Vanier MT, Latour P (2015) Laboratory diagnosis of Niemann-Pick disease type C: the filipin staining test. Methods Cell Biol 126:357–375
Verhoeven NM, Kulik W, van den Heuvel CM, Jakobs C (1995) Pre- and postnatal diagnosis of peroxisomal disorders using stable-isotope dilution gas chromatography--mass spectrometry. J Inherit Metab Dis 18(Suppl 1):45–60
Vianey-Saban C, Bouvier R, Cochat P et al (2000) Antenatal expression of multiple acyl-CoA dehydrogenase deficiency. J Inherit Metab Dis 23:345–348
von Kleist-Retzow JC, Cormier-Daire V, Viot G et al (2003) Antenatal manifestations of mitochondrial respiratory chain deficiency. J Pediatr 143:208–212
Wamelink MM, Struys EA, Valayannopoulos V et al (2008) Retrospective detection of transaldolase deficiency in amniotic fluid: implications for prenatal diagnosis. Prenat Diagn 28:460–462
Waterham HR, Ferdinandusse S, Wanders RJ (2016) Human disorders of peroxisome metabolism and biogenesis. Biochim Biophys Acta 1863:922–933
Wopereis S, Lefeber D, Morava E, Wevers R (2006) Mechanisms in protein O-glycan biosynthesis and clinical and molecular aspects of protein O-glycan biosynthesis: a review. Clin Chem 52:574–600
Yanicostas C, Soussi-Yanicostas N, El-Khoury R et al (2011) Developmental aspects of respiratory chain from fetus to infancy. Semin Fetal Neonatal Med 16:175–180
Zemski Berry KA, Murphy RC (2004) Electrospray ionization tandem mass spectrometry of glycerophosphoethanolamine plasmalogen phospholipids. J Am Soc Mass Spectrom 15:1499–1508
Zolotushko J, Flusser H, Markus B et al (2011) The desmosterolosis phenotype: spasticity, microcephaly and micrognathia with agenesis of corpus callosum and loss of white matter. Eur J Hum Genet 19:942–946
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
None.
Details of funding for all research studies
The authors confirm independence from the sponsors; the content of the article has not been influenced by the sponsors.
Informed consent
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of Helsinki 1975, as revised in 2000. Informed consent was obtained from all patients for inclusion in the study.
Additional information
Communicated by: Carlo Dionisi-Vici
Rights and permissions
About this article
Cite this article
Vianey-Saban, C., Acquaviva, C., Cheillan, D. et al. Antenatal manifestations of inborn errors of metabolism: biological diagnosis. J Inherit Metab Dis 39, 611–624 (2016). https://doi.org/10.1007/s10545-016-9947-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10545-016-9947-8